Edition:
India

U.S. FTC says approves final order settling charges related to DaVita-Renal Ventures deal


Wednesday, 14 Jun 2017 

June 14 (Reuters) - U.S. Federal Trade Commission::Approved final order settling charges that DaVita Inc’s acquisition of Renal Ventures Management would have been anticompetitive. 

Company Quote

52.23
1.18 +2.31%
18 Apr 2019